| abstract |
The present invention is directed to certain quinazoline compounds that are PDE10 inhibitors, pharmaceutical compounds containing the compounds, and methods for preparing the compounds. The present invention is also directed to methods of treating diseases treatable by the PDE10 enzyme, such as obesity, non-insulin dependent diabetes mellitus, schizophrenia or bipolar disorder, obsessive compulsive disorder. [Selection figure] None |